WY-50295

• Target:

  Lipoxygenase

• Related Pathways:

  Metabolism

• Bioactivity:

  WY-50295 is an orally active and selective 5-lipoxygenase inhibitor. In rat whole blood leukocytes, WY-50295 inhibits LTB4 formation with an IC50 of 40 ?M and an oral ED50 of 18 mg/kg. WY-50295 is applicable for research into asthma and other leukotriene-dependent conditions.

• Smiles:

  O(CC1=NC2=C(C=C1)C=CC=C2)C3=CC4=C(C=C([C@@H](C(O)=O)C)C=C4)C=C3

• Molecular Formula:

  C23H19NO3

• Molecular Weight:

  357.4

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  123016-21-7